Tanke Biosciences Stock Revenue
| TNBI Stock | USD 0.02 0.01 33.33% |
Tanke Biosciences fundamentals help investors to digest information that contributes to Tanke Biosciences' financial success or failures. It also enables traders to predict the movement of Tanke Pink Sheet. The fundamental analysis module provides a way to measure Tanke Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tanke Biosciences pink sheet.
Tanke |
Tanke Biosciences Company Revenue Analysis
Tanke Biosciences' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Tanke Biosciences Revenue | 28.56 M |
Most of Tanke Biosciences' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tanke Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Tanke Biosciences reported 28.56 M of revenue. This is 99.75% lower than that of the Financial Services sector and significantly higher than that of the Shell Companies industry. The revenue for all United States stocks is 99.7% higher than that of the company.
Tanke Biosciences is currently regarded number one company in revenue category among its peers. Market size based on revenue of Shell Companies industry is at this time estimated at about 29.1 Million. Tanke Biosciences totals roughly 28.56 Million in revenue claiming about 98% of equities listed under Shell Companies industry.Tanke Fundamentals
| Return On Equity | -0.1 | |||
| Return On Asset | -0.0012 | |||
| Profit Margin | (0.07) % | |||
| Operating Margin | (0) % | |||
| Current Valuation | 4.56 M | |||
| Shares Outstanding | 13.32 M | |||
| Price To Earning | (0.08) X | |||
| Price To Book | 0.02 X | |||
| Price To Sales | 0.09 X | |||
| Revenue | 28.56 M | |||
| Gross Profit | 9.94 M | |||
| EBITDA | 804.29 K | |||
| Net Income | (210.25 K) | |||
| Cash And Equivalents | 5.09 M | |||
| Cash Per Share | 0.38 X | |||
| Debt To Equity | 0.60 % | |||
| Current Ratio | 1.61 X | |||
| Book Value Per Share | 1.17 X | |||
| Cash Flow From Operations | (1.18 M) | |||
| Earnings Per Share | (0.12) X | |||
| Number Of Employees | 130 | |||
| Beta | 0.96 | |||
| Market Capitalization | 2 M | |||
| Total Asset | 28.85 M | |||
| Retained Earnings | 1.62 M | |||
| Working Capital | 7.46 M | |||
| Current Asset | 19.7 M | |||
| Current Liabilities | 12.23 M | |||
| Net Asset | 28.85 M |
About Tanke Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tanke Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tanke Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tanke Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Tanke Pink Sheet
Tanke Biosciences financial ratios help investors to determine whether Tanke Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tanke with respect to the benefits of owning Tanke Biosciences security.